An 86-year-old man presented to the neurology clinic with 2 years of progressive memory loss and difficulty walking. An MRI showed microbleeds that appeared as hypointense foci throughout the ...
The administration recently announced a new payment model to align some Medicare Part B drug payments with international pricing benchmarks. Various factors could affect the model’s scope and impact.
A new pilot Medicaid program — GENEROUS — combines centralized pharmaceutical-coverage negotiations with most-favored-nation pricing in an effort to lower drug costs, but it has some limitations.
Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...
Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...
A 76-year-old woman, who had a history of treated hepatitis C virus infection, presented with rapidly progressive kidney failure and a stroke. Palpable purpura on the legs was noted. A diagnosis ...
The author describes the scientific foundations and implications of the results of a randomized, controlled trial of Mim8, a new mimetic of factor VIIIa, to treat hemophilia A.
Whether treatment with balanced crystalloid fluid leads to better outcomes than 0.9% saline in children treated for septic ...
There has been substantial interest in the development of GLP-1 drugs and optimism about their public health effects. But some worrisome signals related to disordered eating have emerged.
Explore this issue of The New England Journal of Medicine (Vol. 390 No. 10).
Drug-overdose deaths among adolescents have increased in recent years. Steps can be taken to equip adolescents with the knowledge and tools they need to keep themselves safe.
Explore this issue of The New England Journal of Medicine (Vol. 394 No. 3).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results